Daymark Wealth Partners LLC Decreases Stake in Colgate-Palmolive (NYSE:CL)

Daymark Wealth Partners LLC lessened its position in shares of Colgate-Palmolive (NYSE:CL) by 1.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,650 shares of the company’s stock after selling 459 shares during the quarter. Daymark Wealth Partners LLC’s holdings in Colgate-Palmolive were worth $2,150,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. FMR LLC increased its position in Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after purchasing an additional 2,674,807 shares during the last quarter. Barclays PLC grew its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after buying an additional 2,132,747 shares in the last quarter. State Street Corp increased its holdings in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the last quarter. Nordea Investment Management AB raised its position in shares of Colgate-Palmolive by 32.5% during the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after buying an additional 1,247,731 shares in the last quarter. Finally, AQR Capital Management LLC lifted its holdings in shares of Colgate-Palmolive by 58.6% in the 2nd quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company’s stock valued at $234,540,000 after acquiring an additional 892,706 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. UBS Group reduced their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Stifel Nicolaus dropped their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. Wells Fargo & Company decreased their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Piper Sandler dropped their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Finally, StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $101.11.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.37% of the company’s stock.

Colgate-Palmolive Stock Down 0.8 %

NYSE:CL opened at $87.53 on Thursday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a market cap of $71.51 billion, a PE ratio of 25.08, a price-to-earnings-growth ratio of 3.64 and a beta of 0.44. The company has a 50-day moving average of $92.07 and a 200 day moving average of $97.65. Colgate-Palmolive has a 1-year low of $80.03 and a 1-year high of $109.30.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.